Recent Updates
Recently added Catalysts
ENVB Positive Sentiment Score: 75/100

Joseph Tucker – Drugs for Neuroplasticity [The Mindfulness Experience Podcast]

Key Takeaway: In a recent episode of The Mindfulness Experience Podcast, host Keith Fiveson interviews Dr. Joseph Tucker, CEO of Enveric Biosciences. The discussion centers on the company's commitment to developing small-molecule therapeutics aimed at treating anxiety, depression, and addiction disorders. Dr. Tucker's extensive experience in biotechnology is emphasized as a key asset in their mission.

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Joseph Tucker has a strong background in biotechnology.
  • Enveric Biosciences focuses on innovative treatments for mental health.
  • The podcast highlights the importance of addressing anxiety and depression.

Full Press Release Details

In this episode of The Mindfulness Experience Podcast, host Keith Fiveson interviews Dr. Joseph Tucker, the CEO and Director of Enveric Biosciences. Enveric Biosciences is a biotechnology company that is dedicated to developing small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Dr. Tucker has an impressive background in building several publicly traded biotechnology companies and works tirelessly to provide innovative solutions for mental health disorders.
Listen to the Podcast >>

Frequently Asked Questions

What is Enveric Biosciences focused on?

Enveric Biosciences develops therapeutics for anxiety, depression, and addiction.

Who is Dr. Joseph Tucker?

Dr. Joseph Tucker is the CEO and Director of Enveric Biosciences.

What does the podcast discuss?

The podcast discusses innovative solutions for mental health disorders.

Last updated: Nov 4, 2023